A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Clinical trial NCT01984697 · COMPLETED
Trial details
- NCT number
- NCT01984697
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-12
- Primary completion
- 2015-06-19
- Enrollment
- 1518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.